Santen Pharmaceutical Co (PK) (SNPHF)
USOTC
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Return on Assets (%) | 6.799 | 9.915 | 8.194 | 5.429 | 1.638 | 6.306 | -3.401 | 6.233 |
Return on Equity (%) | 8.972 | 13.025 | 11.012 | 7.297 | 2.18 | 8.445 | -4.755 | 8.921 |
Return on Invested Capital (%) | 13.249 | 20.931 | 12.209 | 13.361 | 20.187 | 12.56 | 10.737 | 17.652 |
Operating Margin (%) | 16.009 | 17.465 | 18.944 | 14.006 | 5.207 | 13.47 | -1.779 | 10.606 |
Net Profit Margin (%) | 11.579 | 15.676 | 13.649 | 8.989 | 2.662 | 10.212 | -5.37 | 8.843 |
Book Value Per Share | 371.952 | 376.217 | 403.875 | 456.743 | 484.988 | 515.669 | 524.06 | 608.663 |
Earnings Per Share | 56.759 | 86.669 | 79.901 | 54.281 | 16.597 | 67.855 | -39.86 | 73.361 |
Cash Per Share | 131.217 | 170.292 | 177.087 | 228.559 | 157.075 | 207.175 | 154.044 | 259.844 |
Working Capital Per Share | 255.007 | 297.816 | 335.38 | 377.371 | 318.911 | 333.433 | 329.414 | 393.807 |
Operating Profit Per Share | 311.052 | 357.146 | 386.876 | 409.189 | 459.958 | 434.727 | 497.106 | 530 |
EBIT Per Share | 78.346 | 96.5 | 107.851 | 80.222 | 31.016 | 88.886 | -15.428 | 82.072 |
EBITDA Per Share | 78.346 | 96.5 | 107.851 | 80.222 | 31.016 | 88.886 | -15.428 | 82.072 |
Free Cash Flow Per Share | 58.465 | 97.312 | 82.045 | 38.13 | 37.351 | 122.402 | -13.161 | 59.858 |
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 406,17M | 406,85M | 399,78M | 400,03M | 400,37M | 400,7M | 375,89M | 364M |
Capitalisation boursière | 3,69B |
Ratio cours/bénéfice | 0,15 |
Ratio prix/ventes | 0,01 |
Ratio prix/liquidités | 0,04 |
Ratio prix/valeur comptable | 0,01 |
Rendement de dividende | 29 601,72% |
Actions en circulation | 364M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 611 |
Variation sur 52 semaines | 20,28% |
Plus haut sur 52 semaines | 12,64 |
Plus bas sur 52 semaines | 9,16 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales